Beneficial ownership — 13D / 13G
87,240 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| MORGAN STANLEY | TXG 10x Genomics, Inc. | 13G/A | 3.5% | Nov 30, 2023 | 2y |
| VANGUARD GROUP INC | MURA Mural Oncology plc Ordinary Shares | 13G | 11.17% | Nov 30, 2023 | 2y |
| VANGUARD GROUP INC | CRI Carters Inc | 13G/A | 10.04% | Nov 30, 2023 | 2y |
| NEUBERGER BERMAN GROUP LLC | XPEL XPEL, Inc. | 13G/A | 0% | Nov 30, 2023 | 2y |
| MORGAN STANLEY | GLOB Globant S.A. | 13G/A | 3.4% | Nov 30, 2023 | 2y |
| VANGUARD GROUP INC | RMAX RE/MAX Holdings, Inc. | 13G/A | 5.48% | Nov 30, 2023 | 2y |
| VANGUARD GROUP INC | DG Dollar General Corp | 13G/A | 10.03% | Nov 30, 2023 | 2y |
| CITY OF LONDON INVESTMENT MANAGEMENT CO LTD | IIF Morgan Stanley India Investment Fund, Inc. | 13G/A | 10.3% | Nov 30, 2023 | 2y |
| MORGAN STANLEY | AMRN Amarin Corp Plcuk | 13G/A | 1.6% | Nov 30, 2023 | 2y |
| VANGUARD GROUP INC | QCOM Qualcomm Inc | 13G/A | 10.02% | Nov 30, 2023 | 2y |
| MORGAN STANLEY | MELI Mercadolibre Inc | 13G/A | 3.9% | Nov 30, 2023 | 2y |
| GOLDMAN SACHS GROUP INC | ALOR ALSP Orchid Acquisition Corporation I Class A Ordinary Share | 13G/A | 0% | Nov 30, 2023 | 2y |
| MORGAN STANLEY | CHWY Chewy, Inc. | 13G/A | 4% | Nov 30, 2023 | 2y |
| VANGUARD GROUP INC | KNF Knife River Corp | 13G | 10.76% | Nov 30, 2023 | 2y |
| Altai Capital Management, L.P. | SKYH Sky Harbour Group Corp | 13G | 36.8% | Nov 30, 2023 | 2y |
| CITY OF LONDON INVESTMENT MANAGEMENT CO LTD | ASA ASA Gold & Precious Metals Ltd | 13G/A | 3.1% | Nov 30, 2023 | 2y |
| VANGUARD GROUP INC | BG Bunge Global SA | 13G | 11.45% | Nov 30, 2023 | 2y |
| VANGUARD GROUP INC | DD DuPont de Nemours, Inc. | 13G/A | 10.46% | Nov 30, 2023 | 2y |
| VANGUARD GROUP INC | WSR Whitestone REIT | 13G/A | 11.16% | Nov 30, 2023 | 2y |
| VANGUARD GROUP INC | INCY Incyte Corp | 13G/A | 10.02% | Nov 30, 2023 | 2y |
| VANGUARD GROUP INC | PDCO Patterson Companies, Inc. | 13G/A | 10.02% | Nov 30, 2023 | 2y |
| VANGUARD GROUP INC | HQY Healthequity, Inc. | 13G/A | 10.05% | Nov 30, 2023 | 2y |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | KAI Kadant Inc | 13G | 11.31% | Nov 30, 2023 | 2y |
| MORGAN STANLEY | GHY PGIM Global High Yield Fund, Inc. | 13G/A | 8.3% | Nov 30, 2023 | 2y |
| VANGUARD GROUP INC | NLOP Net Lease Office Properties | 13G | 10.08% | Nov 30, 2023 | 2y |
| MORGAN STANLEY | FOLD AMICUS THERAPEUTICS, INC. | 13G/A | 4.2% | Nov 30, 2023 | 2y |
| CITY OF LONDON INVESTMENT MANAGEMENT CO LTD | IHD Voya Emerging Markets High Dividend Equity Fund | 13G/A | 19.6% | Nov 30, 2023 | 2y |
| MORGAN STANLEY | HEQ John Hancock Diversified Income Fund | 13G/A | 4.2% | Nov 30, 2023 | 2y |
| VANGUARD GROUP INC | IDXX Idexx Laboratories Inc | 13G/A | 10.03% | Nov 30, 2023 | 2y |
| Saba Capital Management, L.P. | DHF Bny Mellon High Yield Strategies Fund | 13D | 5.24% | Nov 29, 2023 | 2y |
| GLAZER CAPITAL, LLC | HT Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest | 13G/A | 0% | Nov 28, 2023 | 2y |
| Growth Equity Opportunities Fund IV, LLC | ADXN Addex Therapeutics Ltd. | 13D/A | 6.4% | Nov 27, 2023 | 2y |
| Aequanimitas Limited Partnership | RANI Rani Therapeutics Holdings, Inc. | 13D/A | 0% | Nov 24, 2023 | 2y |
| South Cone Investments Limited Partnership | RANI Rani Therapeutics Holdings, Inc. | 13D/A | 46.9% | Nov 24, 2023 | 2y |
| James A. Cacioppo | JUSH Jushi Holdings Inc. | 13D/A | 17.95% | Nov 17, 2023 | 2y |
| Burgundy Asset Management Ltd. | BRDG Bridge Investment Group Holdings Inc. | 13G/A | 4.02% | Nov 16, 2023 | 2y |
| Venrock Opportunities Fund, L.P. | VRDN Viridian Therapeutics, Inc.\DE | 13G | 5.2% | Nov 1, 2023 | 2y |
| Kenneth S. Ansin | EBTC Enterprise Bancorp Inc. | 13D | 9.8% | Jun 28, 2023 | 2y |
| Firment Shipping Inc. | GLBS Globus Maritime Ltd | 13D/A | 19% | Dec 6, 2023 | 2y |
| Alex Chesterman | CZOO Cazoo Group Ltd | 13D/A | 1.9% | Dec 6, 2023 | 2y |
| Mill Road Capital III, L.P. | CULP Culp Inc | 13D/A | 5.5% | Dec 5, 2023 | 2y |
| GAMCO INVESTORS, INC. ET AL | MOD Modine Manufacturing Co | 13D/A | 4.51% | Dec 5, 2023 | 2y |
| Hill Path Capital LP | PLAY Dave & Buster's Entertainment, Inc. | 13D/A | 17.7% | Dec 5, 2023 | 2y |
| GIC Private Ltd | YUMC Yum China Holdings, Inc. | 13G | 5.03% | Dec 4, 2023 | 2y |
| William P. Foley, II | SST System1, Inc. | 13G | 5.9% | Dec 4, 2023 | 2y |
| Lind Global Fund II LP | RNAZ Transcode Therapeutics, Inc. | 13G | 9.9% | Dec 4, 2023 | 2y |
| Theofilos Charles Steve | ECOR electroCore, Inc. | 13G | 9.9% | Dec 4, 2023 | 2y |
| THOMPSON DAVIS & CO., INC. | SOHON Sotherly Hotels Inc. | 13D/A | 4.34% | Dec 1, 2023 | 2y |
| Glory Achievement Fund Limited | NIU Niu Technologies | 13D | 31.8% | Nov 30, 2023 | 2y |
| AdvisorShares Trust | PW Power REIT | 13G/A | 3.81% | Nov 30, 2023 | 2y |